Definitive Contract 75F40124C00044

Award Date 4/29/24
Potential Completion Date 4/29/29
Potential Value $4.4M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Leesburg, VA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,996,992.40 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, an SBA-certified 8(a) joint venture. The contract provides scientific, technical, and strategic program management support services to the FDA. It is an 8(a) sole-source award with a period of performance through September 25, 2025. Vets Synergetic Group LLC holds two significant federal contract Indefinite Delivery Vehicles (IDVs) - a single-award Indefinite Delivery...
This is a $223,872.00 firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, a minority-owned, small disadvantaged business structured as a limited liability company and small business joint venture. The contract is for a Project Coordinator V to support the FDA and has a period of performance through January 2026. Vets Synergetic Group LLC holds a single-award Indefinite Delivery Contract (IDC) with the FDA valued at...
This is a firm fixed-price task order awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, a minority-owned small disadvantaged business structured as a limited liability company and small business joint venture. The contract is valued at $3,909,580.24 and has an ultimate completion date of December 4, 2025. The task order falls under a larger single-award Indefinite Delivery Contract (IDC) with the FDA valued at $99,883,020.00, which provides scientific support...
This is a delivery order awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, a minority-owned small disadvantaged business structured as a limited liability company and small business joint venture. The $389,073.60 firm fixed-price contract is for an environmental microbiology research project, with a period of performance through September 2028. Vets Synergetic Group LLC holds a single-award Indefinite Delivery Contract (IDC) with the FDA valued at $99,883,020.00, as...
This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, an SBA-certified 8(a) joint venture small business. The $4,739,716.80 contract provides multiple research scientists to support new and ongoing laboratory research projects. The contract is a labor hours contract with a period of performance ending on September 14, 2027. Vets Synergetic Group LLC is a minority-owned, self-certified small disadvantaged business structured as a limited...
This is a task order award issued under a single-award Indefinite Delivery Contract (IDC) with the Food and Drug Administration (FDA), for the CDER Translational Science Program. The $2,082,859.20 task order was awarded to Vets Synergetic Group LLC, an SBA-certified 8(a) joint venture, on August 30, 2024. The contract has a completion date of September 14, 2027 and is a labor hours contract. Vets Synergetic Group LLC is a minority-owned, small disadvantaged business that provides scientific...
This is a delivery order awarded under Indefinite Delivery Contract (IDC) 75F40124D00020 by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, a minority-owned and small disadvantaged business structured as a limited liability company and small business joint venture. The order is to obtain 7 scientific contract professionals to support the research program of the FDA's Center for Drug Evaluation and Research, Office of Biotechnology Products. The contract has a ceiling value...
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, a minority-owned, small disadvantaged business structured as a limited liability company and small business joint venture. The purpose of this $231,264.00 task order is to procure the services of a Research Assistant II. The award is not associated with a set-aside program and has an ultimate completion date of June 28, 2026. Vets Synergetic Group LLC holds a $99,883,020.00...
This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, a minority-owned, small disadvantaged business structured as a limited liability company and small business joint venture. The contract, valued at $1,054,556.80, is for PROJECT MANAGER II services and has an ultimate completion date of September 29, 2028. The contract is not set aside and is a Labor Hours type with a Pricing Type of Labor Hours. Vets Synergetic Group LLC is an...
This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, a small business and 8(a) joint venture. The $241,228.80 cost-reimbursable contract provides scientific and information technology support services for the Center for Drug Evaluation and Research (CDER) at the FDA. Vets Synergetic Group LLC holds two significant federal contract vehicles: a single-award Indefinite Delivery Contract (IDC) with the FDA valued at $99,883,020.00 for...

This is a $4,395,253.44 definitive, firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, a minority-owned, SBA-certified 8(a) small disadvantaged business joint venture. The contract is for business process integration and solution architecture services, with a performance period from April 29, 2024 to April 29, 2029.

Vets Synergetic Group LLC holds two significant federal contract vehicles: a single-award Indefinite Delivery Contract (IDC) with the FDA valued at $99,883,020.00, as well as a Federal Supply Schedule (FSS) contract with the General Services Administration valued at $475,000.00. These IDVs demonstrate the company's capabilities in delivering comprehensive scientific and technical support to federal agencies, particularly within the pharmaceutical and health research domains. The contract has an 8(a) sole source set-aside designation.

Generated 4/30/25, 10:06 AM